GNPX 2017 Annual Report

F-6 Genprex, Inc. Statements of Cash Flows 2017 2016 Cash flows from operating activities: Net loss $ (3,314,157) $ (4,132,159) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation 3,242 862 Share based compensation 1,323,892 2,657,418 Changes in operating assets and liabilities: Accounts receivable (663) (875) Prepaid expenses and other 4,873 (19,828) Deposits — 2,519 Deferred offering costs (734,084) (25,507) Accounts payable and accrued expenses 545,303 269,307 Net cash used in operating activities (2,171,594) (1,248,263) Cash flows from investing activities: Additions to property and equipment (5,889) (4,978) Additions to intellectual property (57,532) (84,556) Net cash used in investing activities (63,421) (89,534) Cash flows from financing activities: Proceeds from issuances of common stock 793,971 2,705,872 Net cash provided by financing activities 793,971 2,705,872 Net (decrease) increase in cash (1,441,044) 1,368,075 Cash, beginning of year 1,602,295 234,220 Cash, end of year $ 161,251 $ 1,602,295 See accompanying notes to the financial statements